Alpha Tau Medical Appoints Nadav Kidron to Board
Ticker: DRTSW · Form: 6-K · Filed: May 12, 2025 · CIK: 1871321
| Field | Detail |
|---|---|
| Company | Alpha Tau Medical Ltd. (DRTSW) |
| Form Type | 6-K |
| Filed Date | May 12, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-appointment, management
TL;DR
Alpha Tau Medical adds Nadav Kidron to its Board of Directors.
AI Summary
On May 12, 2025, Alpha Tau Medical Ltd. announced the appointment of Nadav Kidron to its Board of Directors. Kidron's appointment is detailed in a press release attached to the company's Form 6-K filing.
Why It Matters
The appointment of a new board member can signal strategic shifts or enhanced leadership within a company, potentially impacting investor confidence and future direction.
Risk Assessment
Risk Level: low — This filing is a routine report of a board appointment and does not contain significant financial or operational news.
Key Players & Entities
- Alpha Tau Medical Ltd. (company) — Registrant
- Nadav Kidron (person) — Appointed to Board of Directors
FAQ
What is the exact date of the press release announcing Nadav Kidron's appointment?
The press release announcing Nadav Kidron's appointment was issued on May 12, 2025.
Which exhibit contains the press release about the board appointment?
The press release is attached to the Form 6-K as Exhibit 99.1.
What is Alpha Tau Medical Ltd.'s principal executive office address?
Alpha Tau Medical Ltd.'s principal executive office is located at Kiryat HaMada St. 5, Jerusalem, Israel, 9777605.
Does Alpha Tau Medical Ltd. file annual reports under Form 20-F or Form 40-F?
Alpha Tau Medical Ltd. indicates it files annual reports under Form 20-F.
Under which section of the Securities Exchange Act is this Form 6-K filed?
This Form 6-K is filed pursuant to Section 13A-16 or 15D-16 under the Securities Exchange Act of 1934.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 12, 2025 by Nadav Kidron regarding Alpha Tau Medical Ltd. (DRTSW).